Work

Epothilone B analog (BMS-247550) at the recommended phase II dose (RPTD) in patients (pts) with gynecologic (gyn) and breast cancers

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.2115

Authors: T. Chen, A. Molina, S. Moore, S. Goel, K. Desai, A. Hamilton, T. Griffin, A. D. Colevas, S. Mani, F. Muggia

Institutions: Albert Einstein College of Medicine, NYU Langone Health, Bristol-Myers Squibb (United States), New York University

Language: English

Topic: Cancer Treatment and Pharmacology

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2253977507

Cites:

Cited by: 18

Related to: 10